Definitive Contract 75A50119C00071
Award Date
8/30/19
Potential Completion Date
8/29/29
Potential Value
$749M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Gaithersburg, MD 20879, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,403,362,669.10 cost-plus-fixed-fee contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Product Development Gaithersburg Inc., a for-profit limited liability company manufacturing medical countermeasures and pharmaceuticals. The contract, which has a period of performance through September 29, 2026, is for the development of filovirus treatments. Emergent has received over $1.3...
The U.S. Department of Health and Human Services (HHS), through the Office of the Assistant Secretary for Preparedness and Response (ASPR), awarded a $630,384,987.00 firm-fixed-price definitive contract to Emergent BioDefense Operations Lansing LLC for the advanced research and development of a smallpox antiviral drug. This award is not associated with a set-aside contract and is part of ASPR's broader efforts to procure and stockpile alternative smallpox antivirals. The original procurement was...
This is a $19,763,563.00 cost-plus-fixed-fee delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Emergent Manufacturing Operations Baltimore LLC, a for-profit limited liability company and manufacturer of goods registered in the System for Award Management (SAM). The contract is part of the Centers for Innovation in Advanced...
This is a $762,812,695.00 firm fixed price contract awarded by the U.S. Department of Health and Human Services' (HHS) Biomedical Advanced Research and Development Authority (BARDA) to Emergent Product Development Gaithersburg Inc., a for-profit manufacturer of medical countermeasures. The contract is for the development of medical countermeasures that can be deployed in the event of a filovirus outbreak, which is a crucial component of the U.S. government's outbreak response plan. The...
This is a $30,559,760.00 cost-plus-fixed-fee delivery order awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Manufacturing Operations Baltimore LLC, a for-profit manufacturer of medical countermeasures. The contract is for the development of the MAPP biopharmaceutical Viral Hemorrhagic Fever (VHF) Medical Countermeasure (MCM) platform. This work is being performed under the Centers for Innovation in...
This is a $7,935,685.07 Cost Plus Fixed Fee delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response, which is part of the U.S. Department of Health and Human Services, to Emergent Manufacturing Operations Baltimore LLC, a for-profit manufacturer of medical countermeasures. The contract is for testing and shelf-life extension of a U.S. Government-owned adjuvant for pandemic preparedness, under the Centers for Innovation in Advanced Development and...
This is a $93,164,303.39 cost plus fixed fee definitive contract awarded by the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response, to Janssen Vaccines & Prevention B.V. (JPC), a foreign-owned for-profit organization, on September 14, 2015. The contract has an ultimate completion date of August 16, 2024 and is not set-aside. The contract is for products and services related to HHS's preparedness and response programs, though...
This federal contract award is for BAXTER CELL HARVEST services in year 6 of the contract, awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Emergent Biodefense Operations Lansing LLC, doing business as Emergent Biodefense. The contract has a ceiling value of $38,250,000.00 and was awarded on September 30, 2016, with an ultimate completion date of August 31, 2018. It is a Firm Fixed Price delivery order contract. Emergent Biodefense is a for-profit manufacturer of...
This is a $23,109,340.68 cost-plus-fixed-fee delivery order awarded to Emergent Manufacturing Operations Baltimore LLC, a for-profit limited liability company manufacturer, by the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services. The contract is for the development of a plasma-derived polyclonal antibody-based COVID-19 therapeutic, under the Centers for Innovation in Advanced Development and Manufacturing program. No...
This is a federal contract award to Protein Sciences Corp, a for-profit vaccine manufacturer, by the U.S. Department of Health and Human Services' (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The $2,146,389.00 firm fixed-price contract is a delivery order under ASPR's Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The purpose of the award is for Protein Sciences to manufacture 1 bulk lot of an H7 vaccine. No set-aside designation was...